Psychiatric News (2/16) reports “switching patients with serious mental illness who are taking one or more antipsychotics to aripiprazole or ziprasidone may lead to weight loss and other cardiometabolic improvements,” according to a meta-analysis published in Schizophrenia Bulletin. The researchers “analyzed 61 articles, which described studies of 8,554 people (mean age, 39 years) – the majority of whom had been diagnosed with schizophrenia or schizoaffective disorder, bipolar disorder, or comorbid mental disorders.”
Related Links:
— “Switching to Aripiprazole or Ziprasidone May Reduce Weight Gain in Patients Taking Antipsychotics, Psychiatric News, February 16, 2021